Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder

Zhiming Cai and colleagues report the exome sequencing of tumor and matched normal tissue from nine transitional cell carcinomas (TCCs) of the bladder, with further screening in 88 additional subjects. The authors identify mutations in chromatin remodeling genes in 59% of the 97 TCC subjects. Transi...

Full description

Saved in:
Bibliographic Details
Published inNature genetics Vol. 43; no. 9; pp. 875 - 878
Main Authors Gui, Yaoting, Guo, Guangwu, Huang, Yi, Hu, Xueda, Tang, Aifa, Gao, Shengjie, Wu, Renhua, Chen, Chao, Li, Xianxin, Zhou, Liang, He, Minghui, Li, Zesong, Sun, Xiaojuan, Jia, Wenlong, Chen, Jinnong, Yang, Shangming, Zhou, Fangjian, Zhao, Xiaokun, Wan, Shengqing, Ye, Rui, Liang, Chaozhao, Liu, Zhisheng, Huang, Peide, Liu, Chunxiao, Jiang, Hui, Wang, Yong, Zheng, Hancheng, Sun, Liang, Liu, Xingwang, Jiang, Zhimao, Feng, Dafei, Chen, Jing, Wu, Song, Zou, Jing, Zhang, Zhongfu, Yang, Ruilin, Zhao, Jun, Xu, Congjie, Yin, Weihua, Guan, Zhichen, Ye, Jiongxian, Zhang, Hong, Li, Jingxiang, Kristiansen, Karsten, Nickerson, Michael L, Theodorescu, Dan, Li, Yingrui, Zhang, Xiuqing, Li, Songgang, Wang, Jian, Yang, Huanming, Wang, Jun, Cai, Zhiming
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.09.2011
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Zhiming Cai and colleagues report the exome sequencing of tumor and matched normal tissue from nine transitional cell carcinomas (TCCs) of the bladder, with further screening in 88 additional subjects. The authors identify mutations in chromatin remodeling genes in 59% of the 97 TCC subjects. Transitional cell carcinoma (TCC) is the most common type of bladder cancer. Here we sequenced the exomes of nine individuals with TCC and screened all the somatically mutated genes in a prevalence set of 88 additional individuals with TCC with different tumor stages and grades. In our study, we discovered a variety of genes previously unknown to be mutated in TCC. Notably, we identified genetic aberrations of the chromatin remodeling genes ( UTX, MLL - MLL3 , CREBBP - EP300 , NCOR1 , ARID1A and CHD6 ) in 59% of our 97 subjects with TCC. Of these genes, we showed UTX to be altered substantially more frequently in tumors of low stages and grades, highlighting its potential role in the classification and diagnosis of bladder cancer. Our results provide an overview of the genetic basis of TCC and suggest that aberration of chromatin regulation might be a hallmark of bladder cancer.
AbstractList Transitional cell carcinoma (TCC) is the most common type of bladder cancer. Here we sequenced the exomes of nine individuals with TCC and screened all the somatically mutated genes in a prevalence set of 88 additional individuals with TCC with different tumor stages and grades. In our study, we discovered a variety of genes previously unknown to be mutated in TCC. Notably, we identified genetic aberrations of the chromatin remodeling genes (UTX, MLL-MLL3, CREBBP-EP300, NCOR1, ARID1A and CHD6) in 59% of our 97 subjects with TCC. Of these genes, we showed UTX to be altered substantially more frequently in tumors of low stages and grades, highlighting its potential role in the classification and diagnosis of bladder cancer. Our results provide an overview of the genetic basis of TCC and suggest that aberration of chromatin regulation might be a hallmark of bladder cancer. [PUBLICATION ABSTRACT]
Transitional cell carcinoma (TCC) is the most common type of bladder cancer. Here we sequenced the exomes of nine individuals with TCC and screened all the somatically mutated genes in a prevalence set of 88 additional individuals with TCC with different tumor stages and grades. In our study, we discovered a variety of genes previously unknown to be mutated in TCC. Notably, we identified genetic aberrations of the chromatin remodeling genes (UTX, MLL-MLL3, CREBBP-EP300, NCOR1, ARID1A and CHD6) in 59% of our 97 subjects with TCC. Of these genes, we showed UTX to be altered substantially more frequently in tumors of low stages and grades, highlighting its potential role in the classification and diagnosis of bladder cancer. Our results provide an overview of the genetic basis of TCC and suggest that aberration of chromatin regulation might be a hallmark of bladder cancer.
Transitional cell carcinoma (TCC) is the most common type of bladder cancer. Here we sequenced the exomes of nine individuals with TCC and screened all the somatically mutated genes in a prevalence set of 88 additional individuals with TCC with different tumor stages and grades. In our study, we discovered a variety of genes previously unknown to be mutated in TCC. Notably, we identified genetic aberrations of the chromatin remodeling genes ( UTX, MLL - MLL3 , CREBBP-EP300 , NCOR1 , ARID1A and CHD6 ) in 59% of our 97 subjects with TCC. Of these genes, we showed UTX to be altered substantially more frequently in tumors of low stages and grades, highlighting its potential role in the classification and diagnosis of bladder cancer. Our results provide an overview of the genetic basis of TCC and suggest that aberration of chromatin regulation might be a hallmark of bladder cancer.
Transitional cell carcinoma (TCC) is the most common type of bladder cancer. Here we sequenced the exomes of nine individuals with TCC and screened all the somatically mutated genes in a prevalence set of 88 additional individuals with TCC with different tumor stages and grades. In our study, we discovered a variety of genes previously unknown to be mutated in TCC. Notably, we identified genetic aberrations of the chromatin remodeling genes (UTX, MLL-MLL3, CREBBP-EP300, NCOR1, ARID1A and CHD6) in 59% of our 97 subjects with TCC. Of these genes, we showed UTX to be altered substantially more frequently in tumors of low stages and grades, highlighting its potential role in the classification and diagnosis of bladder cancer. Our results provide an overview of the genetic basis of TCC and suggest that aberration of chromatin regulation might be a hallmark of bladder cancer.Transitional cell carcinoma (TCC) is the most common type of bladder cancer. Here we sequenced the exomes of nine individuals with TCC and screened all the somatically mutated genes in a prevalence set of 88 additional individuals with TCC with different tumor stages and grades. In our study, we discovered a variety of genes previously unknown to be mutated in TCC. Notably, we identified genetic aberrations of the chromatin remodeling genes (UTX, MLL-MLL3, CREBBP-EP300, NCOR1, ARID1A and CHD6) in 59% of our 97 subjects with TCC. Of these genes, we showed UTX to be altered substantially more frequently in tumors of low stages and grades, highlighting its potential role in the classification and diagnosis of bladder cancer. Our results provide an overview of the genetic basis of TCC and suggest that aberration of chromatin regulation might be a hallmark of bladder cancer.
Transitional cell carcinoma (TCC) is the most common type of bladder cancer. Here we sequenced the exomes of nine individuals with TCC and screened all the somatically mutated genes in a prevalence set of 88 additional individuals with TCC with different tumor stages and grades. In our study, we discovered a variety of genes previously unknown to be mutated in TCC. Notably, we identified genetic aberrations of the chromatin remodeling genes (UTX, MLL-MLL3, CREBBPEP300, NCOR1, ARID1A and CHD6) in 59% of our 97 subjects with TCC. Of these genes, we showed UTX to be altered substantially more frequently in tumors of low stages and grades, highlighting its potential role in the classification and diagnosis of bladder cancer. Our results provide an overview of the genetic basis of TCC and suggest that aberration of chromatin regulation might be a hallmark of bladder cancer.
Zhiming Cai and colleagues report the exome sequencing of tumor and matched normal tissue from nine transitional cell carcinomas (TCCs) of the bladder, with further screening in 88 additional subjects. The authors identify mutations in chromatin remodeling genes in 59% of the 97 TCC subjects. Transitional cell carcinoma (TCC) is the most common type of bladder cancer. Here we sequenced the exomes of nine individuals with TCC and screened all the somatically mutated genes in a prevalence set of 88 additional individuals with TCC with different tumor stages and grades. In our study, we discovered a variety of genes previously unknown to be mutated in TCC. Notably, we identified genetic aberrations of the chromatin remodeling genes ( UTX, MLL - MLL3 , CREBBP - EP300 , NCOR1 , ARID1A and CHD6 ) in 59% of our 97 subjects with TCC. Of these genes, we showed UTX to be altered substantially more frequently in tumors of low stages and grades, highlighting its potential role in the classification and diagnosis of bladder cancer. Our results provide an overview of the genetic basis of TCC and suggest that aberration of chromatin regulation might be a hallmark of bladder cancer.
Audience Academic
Author Liu, Zhisheng
Li, Songgang
Nickerson, Michael L
Wan, Shengqing
Wang, Yong
Sun, Xiaojuan
Chen, Chao
Zheng, Hancheng
Gao, Shengjie
Sun, Liang
Ye, Rui
Wu, Song
Jia, Wenlong
Liu, Xingwang
Tang, Aifa
Zhang, Zhongfu
Feng, Dafei
Li, Jingxiang
Yang, Huanming
Zhang, Xiuqing
Chen, Jinnong
Li, Xianxin
He, Minghui
Zhou, Liang
Yang, Shangming
Xu, Congjie
Yin, Weihua
Gui, Yaoting
Liang, Chaozhao
Hu, Xueda
Huang, Peide
Li, Zesong
Yang, Ruilin
Theodorescu, Dan
Ye, Jiongxian
Zhao, Jun
Kristiansen, Karsten
Jiang, Zhimao
Guan, Zhichen
Cai, Zhiming
Wang, Jian
Guo, Guangwu
Zhou, Fangjian
Jiang, Hui
Zhang, Hong
Zou, Jing
Huang, Yi
Wu, Renhua
Wang, Jun
Li, Yingrui
Liu, Chunxiao
Zhao, Xiaokun
Chen, Jing
AuthorAffiliation 7 Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
9 Cancer and Inflammation Program, National Cancer Institute, US National Institutes of Health (NIH), Frederick, Maryland, USA
10 Department of Surgery, University of Colorado Comprehensive Cancer Center, Aurora, Colorado, USA
8 Department of Biology, University of Copenhagen, Copenhagen, Denmark
11 Department of Pharmacology, University of Colorado Comprehensive Cancer Center, Aurora, Colorado, USA
6 Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
3 Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
4 Department of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, China
2 BGI-Shenzhen, Shenzhen, China
5 Department of Urology, the Second Xiangya Hospital of Central-Southern University, Changsha, China
1 Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Uro
AuthorAffiliation_xml – name: 6 Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
– name: 9 Cancer and Inflammation Program, National Cancer Institute, US National Institutes of Health (NIH), Frederick, Maryland, USA
– name: 10 Department of Surgery, University of Colorado Comprehensive Cancer Center, Aurora, Colorado, USA
– name: 4 Department of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, China
– name: 1 Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen, China
– name: 8 Department of Biology, University of Copenhagen, Copenhagen, Denmark
– name: 11 Department of Pharmacology, University of Colorado Comprehensive Cancer Center, Aurora, Colorado, USA
– name: 2 BGI-Shenzhen, Shenzhen, China
– name: 5 Department of Urology, the Second Xiangya Hospital of Central-Southern University, Changsha, China
– name: 3 Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
– name: 7 Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
Author_xml – sequence: 1
  givenname: Yaoting
  surname: Gui
  fullname: Gui, Yaoting
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 2
  givenname: Guangwu
  surname: Guo
  fullname: Guo, Guangwu
  organization: BGI-Shenzhen
– sequence: 3
  givenname: Yi
  surname: Huang
  fullname: Huang, Yi
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 4
  givenname: Xueda
  surname: Hu
  fullname: Hu, Xueda
  organization: BGI-Shenzhen
– sequence: 5
  givenname: Aifa
  surname: Tang
  fullname: Tang, Aifa
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University
– sequence: 6
  givenname: Shengjie
  surname: Gao
  fullname: Gao, Shengjie
  organization: BGI-Shenzhen
– sequence: 7
  givenname: Renhua
  surname: Wu
  fullname: Wu, Renhua
  organization: BGI-Shenzhen
– sequence: 8
  givenname: Chao
  surname: Chen
  fullname: Chen, Chao
  organization: BGI-Shenzhen
– sequence: 9
  givenname: Xianxin
  surname: Li
  fullname: Li, Xianxin
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 10
  givenname: Liang
  surname: Zhou
  fullname: Zhou, Liang
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 11
  givenname: Minghui
  surname: He
  fullname: He, Minghui
  organization: BGI-Shenzhen
– sequence: 12
  givenname: Zesong
  surname: Li
  fullname: Li, Zesong
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University
– sequence: 13
  givenname: Xiaojuan
  surname: Sun
  fullname: Sun, Xiaojuan
  organization: Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University
– sequence: 14
  givenname: Wenlong
  surname: Jia
  fullname: Jia, Wenlong
  organization: BGI-Shenzhen
– sequence: 15
  givenname: Jinnong
  surname: Chen
  fullname: Chen, Jinnong
  organization: BGI-Shenzhen
– sequence: 16
  givenname: Shangming
  surname: Yang
  fullname: Yang, Shangming
  organization: BGI-Shenzhen
– sequence: 17
  givenname: Fangjian
  surname: Zhou
  fullname: Zhou, Fangjian
  organization: Department of Urology, Sun Yat-Sen University Cancer Center
– sequence: 18
  givenname: Xiaokun
  surname: Zhao
  fullname: Zhao, Xiaokun
  organization: Department of Urology, the Second Xiangya Hospital of Central-Southern University
– sequence: 19
  givenname: Shengqing
  surname: Wan
  fullname: Wan, Shengqing
  organization: BGI-Shenzhen
– sequence: 20
  givenname: Rui
  surname: Ye
  fullname: Ye, Rui
  organization: BGI-Shenzhen
– sequence: 21
  givenname: Chaozhao
  surname: Liang
  fullname: Liang, Chaozhao
  organization: Department of Urology, The First Affiliated Hospital of Anhui Medical University
– sequence: 22
  givenname: Zhisheng
  surname: Liu
  fullname: Liu, Zhisheng
  organization: BGI-Shenzhen
– sequence: 23
  givenname: Peide
  surname: Huang
  fullname: Huang, Peide
  organization: BGI-Shenzhen
– sequence: 24
  givenname: Chunxiao
  surname: Liu
  fullname: Liu, Chunxiao
  organization: Department of Urology, Zhujiang Hospital, Southern Medical University
– sequence: 25
  givenname: Hui
  surname: Jiang
  fullname: Jiang, Hui
  organization: BGI-Shenzhen
– sequence: 26
  givenname: Yong
  surname: Wang
  fullname: Wang, Yong
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 27
  givenname: Hancheng
  surname: Zheng
  fullname: Zheng, Hancheng
  organization: BGI-Shenzhen
– sequence: 28
  givenname: Liang
  surname: Sun
  fullname: Sun, Liang
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 29
  givenname: Xingwang
  surname: Liu
  fullname: Liu, Xingwang
  organization: BGI-Shenzhen
– sequence: 30
  givenname: Zhimao
  surname: Jiang
  fullname: Jiang, Zhimao
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 31
  givenname: Dafei
  surname: Feng
  fullname: Feng, Dafei
  organization: BGI-Shenzhen
– sequence: 32
  givenname: Jing
  surname: Chen
  fullname: Chen, Jing
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 33
  givenname: Song
  surname: Wu
  fullname: Wu, Song
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 34
  givenname: Jing
  surname: Zou
  fullname: Zou, Jing
  organization: BGI-Shenzhen
– sequence: 35
  givenname: Zhongfu
  surname: Zhang
  fullname: Zhang, Zhongfu
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 36
  givenname: Ruilin
  surname: Yang
  fullname: Yang, Ruilin
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 37
  givenname: Jun
  surname: Zhao
  fullname: Zhao, Jun
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 38
  givenname: Congjie
  surname: Xu
  fullname: Xu, Congjie
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 39
  givenname: Weihua
  surname: Yin
  fullname: Yin, Weihua
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 40
  givenname: Zhichen
  surname: Guan
  fullname: Guan, Zhichen
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 41
  givenname: Jiongxian
  surname: Ye
  fullname: Ye, Jiongxian
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 42
  givenname: Hong
  surname: Zhang
  fullname: Zhang, Hong
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center
– sequence: 43
  givenname: Jingxiang
  surname: Li
  fullname: Li, Jingxiang
  organization: BGI-Shenzhen
– sequence: 44
  givenname: Karsten
  surname: Kristiansen
  fullname: Kristiansen, Karsten
  organization: BGI-Shenzhen, Department of Biology, University of Copenhagen
– sequence: 45
  givenname: Michael L
  surname: Nickerson
  fullname: Nickerson, Michael L
  organization: Cancer and Inflammation Program, National Cancer Institute, US National Institutes of Health (NIH)
– sequence: 46
  givenname: Dan
  surname: Theodorescu
  fullname: Theodorescu, Dan
  organization: Department of Surgery, University of Colorado Comprehensive Cancer Center, Department of Pharmacology, University of Colorado Comprehensive Cancer Center
– sequence: 47
  givenname: Yingrui
  surname: Li
  fullname: Li, Yingrui
  organization: BGI-Shenzhen
– sequence: 48
  givenname: Xiuqing
  surname: Zhang
  fullname: Zhang, Xiuqing
  organization: BGI-Shenzhen
– sequence: 49
  givenname: Songgang
  surname: Li
  fullname: Li, Songgang
  organization: BGI-Shenzhen
– sequence: 50
  givenname: Jian
  surname: Wang
  fullname: Wang, Jian
  organization: BGI-Shenzhen
– sequence: 51
  givenname: Huanming
  surname: Yang
  fullname: Yang, Huanming
  email: yanghm@genomics.org.cn
  organization: BGI-Shenzhen
– sequence: 52
  givenname: Jun
  surname: Wang
  fullname: Wang, Jun
  email: wangj@genomics.org.cn
  organization: BGI-Shenzhen, Department of Biology, University of Copenhagen
– sequence: 53
  givenname: Zhiming
  surname: Cai
  fullname: Cai, Zhiming
  email: caizhiming2000@yahoo.com.cn
  organization: Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24566411$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21822268$$D View this record in MEDLINE/PubMed
BookMark eNqNku1r1TAUh4NM3HbVP0GK4hvYa5KmafplMIbTwWDg20dDmia9GW0yk1bmf--p97p5ryJS6Ev6nB_Jc84h2vPBG4QeErwkuBCvfbescXUHHZCS8ZxUROzBO-YkZ7jg--gwpUuMCWNY3EP7lAhKKRcH6MtpNF8n48dsmEY1uuBTFmymVzEM8OmzaIbQmt75LuuMNymDtTEqn9wMqz7Tpoebitp5KJmLx5XJml61rYn30V2r-mQebJ4L9On0zceTd_n5xduzk-PzXHMhxpzjWtcNt7awVc2NYYo2thG2oJzXNeO6ohQzTouyokbgtqCkAbQiNbcKV7pYoKN17tXUDKbVcKCoenkV3aDidxmUk9t_vFvJLnyTZVEVghEIeL4JiAF8pFEOLs1HU96EKUkhSvBbwhYW6MU_SWgHE6QkP0Mf76CXYYogDfJqRujcGoCerKFO9UY6bwNsUM-Z8pjyikGjCANq-RcKrtYMTsMsWAfrWwUvtwqAGc312KkpJXn24f3_sxeft9lHv5u-UfxrpAB4ugFU0qq3MCvapVuOlZwzMst5tuZ0DClFY28QgmeJQvpOgnMAX-2A2q1HFRS4_k9808kEeb4z8Vb6DvkDtvMA5g
CODEN NGENEC
CitedBy_id crossref_primary_10_1016_j_trecan_2016_09_002
crossref_primary_10_1200_JCO_2013_53_2465
crossref_primary_10_1158_1078_0432_CCR_13_0280
crossref_primary_10_1097_PAP_0000000000000050
crossref_primary_10_18632_oncotarget_27988
crossref_primary_10_1073_pnas_1318376111
crossref_primary_10_1002_ijc_28654
crossref_primary_10_1021_pr400143x
crossref_primary_10_1016_j_ctarc_2023_100779
crossref_primary_10_1093_abbs_gmr099
crossref_primary_10_1016_j_eururo_2016_01_007
crossref_primary_10_1016_j_eururo_2017_03_010
crossref_primary_10_1002_ctm2_1062
crossref_primary_10_1111_cas_12065
crossref_primary_10_1002_cncy_22410
crossref_primary_10_1371_journal_pone_0233394
crossref_primary_10_3390_ijms150611142
crossref_primary_10_1101_gad_255182_114
crossref_primary_10_3390_diseases12090219
crossref_primary_10_1517_13543784_2014_966900
crossref_primary_10_1016_j_urolonc_2016_03_012
crossref_primary_10_1038_s41467_018_06616_0
crossref_primary_10_1038_nm_4036
crossref_primary_10_3389_fgene_2019_01125
crossref_primary_10_1093_nar_gkab864
crossref_primary_10_1016_j_eururo_2014_06_050
crossref_primary_10_3109_00365521_2015_1119305
crossref_primary_10_1016_j_gendis_2023_01_019
crossref_primary_10_3109_10408363_2014_914888
crossref_primary_10_1186_s12935_020_01731_9
crossref_primary_10_1073_pnas_1303607110
crossref_primary_10_1096_fj_202201002RR
crossref_primary_10_1016_j_pharmthera_2014_06_004
crossref_primary_10_1038_ng_2846
crossref_primary_10_1158_1078_0432_CCR_17_1140
crossref_primary_10_1371_journal_pone_0111516
crossref_primary_10_1042_BST20191164
crossref_primary_10_1093_bfgp_elx018
crossref_primary_10_1016_j_jgg_2018_10_001
crossref_primary_10_1016_j_modpat_2023_100120
crossref_primary_10_3233_CBM_160003
crossref_primary_10_1002_ijc_29526
crossref_primary_10_1371_journal_pone_0033834
crossref_primary_10_1126_sciadv_add3339
crossref_primary_10_1016_j_pharmthera_2015_07_004
crossref_primary_10_1007_s00795_021_00301_w
crossref_primary_10_1200_JCO_2012_46_8934
crossref_primary_10_1016_j_prp_2020_153156
crossref_primary_10_1111_ejh_12039
crossref_primary_10_1093_gastro_goaa025
crossref_primary_10_1093_nar_gkr952
crossref_primary_10_1016_j_bbrc_2014_08_004
crossref_primary_10_1016_j_ccell_2019_01_001
crossref_primary_10_1038_ncb3473
crossref_primary_10_1038_onc_2011_552
crossref_primary_10_1371_journal_pone_0040364
crossref_primary_10_1007_s12308_023_00567_2
crossref_primary_10_3390_cancers10040100
crossref_primary_10_1038_nbt_2681
crossref_primary_10_1038_onc_2012_586
crossref_primary_10_1158_0008_5472_CAN_16_1099
crossref_primary_10_3892_or_2015_4421
crossref_primary_10_1016_j_eururo_2015_07_039
crossref_primary_10_18632_oncotarget_1555
crossref_primary_10_1146_annurev_pathol_012513_104703
crossref_primary_10_3389_fimmu_2024_1444923
crossref_primary_10_1002_ajmg_c_31410
crossref_primary_10_1016_j_molcel_2022_12_031
crossref_primary_10_1101_cshperspect_a026930
crossref_primary_10_1038_ng_2508
crossref_primary_10_1038_ng_2628
crossref_primary_10_1111_his_12566
crossref_primary_10_3390_genes14051008
crossref_primary_10_1146_annurev_genom_090711_163752
crossref_primary_10_1007_s12253_013_9668_3
crossref_primary_10_1093_annonc_mdw552
crossref_primary_10_1111_bph_12848
crossref_primary_10_1038_nrurol_2017_179
crossref_primary_10_1038_nrc3486
crossref_primary_10_18632_oncotarget_3502
crossref_primary_10_1158_1541_7786_MCR_16_0123
crossref_primary_10_2147_OTT_S286867
crossref_primary_10_1016_j_ebiom_2016_08_036
crossref_primary_10_12688_f1000research_26841_1
crossref_primary_10_1097_JTO_0000000000000397
crossref_primary_10_1016_j_pharmthera_2012_11_002
crossref_primary_10_3389_fcell_2021_713499
crossref_primary_10_1093_nar_gku1393
crossref_primary_10_3390_cancers16040803
crossref_primary_10_3390_ijms231911075
crossref_primary_10_5858_arpa_2018_0329_RA
crossref_primary_10_1002_humu_22346
crossref_primary_10_2217_pgs_2017_0055
crossref_primary_10_1371_journal_pone_0078652
crossref_primary_10_15252_embr_201540244
crossref_primary_10_1038_onc_2014_196
crossref_primary_10_1177_03000605211049946
crossref_primary_10_3802_jgo_2013_24_4_376
crossref_primary_10_7314_APJCP_2015_16_7_2725
crossref_primary_10_7717_peerj_8261
crossref_primary_10_3390_ijms24129854
crossref_primary_10_1093_bioinformatics_btt183
crossref_primary_10_1007_s12015_021_10234_7
crossref_primary_10_1007_s00432_023_04886_w
crossref_primary_10_1186_s13046_019_1089_z
crossref_primary_10_1016_j_pharmthera_2015_01_002
crossref_primary_10_3390_cells11050808
crossref_primary_10_1038_nrd4154
crossref_primary_10_1371_journal_pone_0259992
crossref_primary_10_18632_oncotarget_16765
crossref_primary_10_3390_epigenomes1010004
crossref_primary_10_1186_s13046_015_0164_3
crossref_primary_10_1016_j_euf_2015_09_007
crossref_primary_10_2217_epi_12_3
crossref_primary_10_1126_science_aba8347
crossref_primary_10_1016_j_eururo_2016_02_028
crossref_primary_10_3390_cancers14061416
crossref_primary_10_4161_cbt_19590
crossref_primary_10_1101_gad_191163_112
crossref_primary_10_1016_j_tranon_2015_08_002
crossref_primary_10_7554_eLife_01279
crossref_primary_10_1111_j_1750_3639_2011_00536_x
crossref_primary_10_18632_oncotarget_3879
crossref_primary_10_1038_srep06036
crossref_primary_10_1158_2159_8290_CD_16_0745
crossref_primary_10_1016_j_ymthe_2020_09_004
crossref_primary_10_1016_j_xgen_2022_100179
crossref_primary_10_1038_ncb3038
crossref_primary_10_3390_ijms21249340
crossref_primary_10_1186_s10020_022_00469_6
crossref_primary_10_1038_s41392_019_0040_2
crossref_primary_10_1016_j_acthis_2022_151847
crossref_primary_10_1002_prca_201700074
crossref_primary_10_1016_j_canlet_2020_05_025
crossref_primary_10_1038_s41418_019_0278_9
crossref_primary_10_1016_j_phrs_2016_04_027
crossref_primary_10_18632_oncotarget_25251
crossref_primary_10_3390_ijms20061291
crossref_primary_10_1038_nrc3130
crossref_primary_10_1093_jnci_djab067
crossref_primary_10_1097_PPO_0000000000000283
crossref_primary_10_1002_cso2_1027
crossref_primary_10_18632_oncotarget_17872
crossref_primary_10_3390_ijms231810339
crossref_primary_10_3389_fcell_2020_561804
crossref_primary_10_1038_s41467_019_08576_5
crossref_primary_10_1038_s41598_020_66747_7
crossref_primary_10_1016_j_canlet_2018_01_046
crossref_primary_10_3233_BLC_160053
crossref_primary_10_1002_jhbp_246
crossref_primary_10_1158_1535_7163_MCT_15_0618
crossref_primary_10_1039_C6MD00297H
crossref_primary_10_1158_2159_8290_CD_15_0754
crossref_primary_10_1111_cas_14884
crossref_primary_10_1038_nrurol_2017_11
crossref_primary_10_1016_j_ajhg_2013_07_003
crossref_primary_10_1586_erm_12_10
crossref_primary_10_3390_cells11233825
crossref_primary_10_1002_stem_1625
crossref_primary_10_1016_S1470_2045_13_70591_6
crossref_primary_10_1186_s12967_022_03522_4
crossref_primary_10_1080_14737140_2019_1605905
crossref_primary_10_1007_s13277_014_1755_x
crossref_primary_10_1074_jbc_R111_309302
crossref_primary_10_1038_s41591_018_0034_6
crossref_primary_10_1186_s13148_024_01805_9
crossref_primary_10_1172_JCI169993
crossref_primary_10_18632_oncotarget_6380
crossref_primary_10_1097_MOU_0b013e32835e9ef4
crossref_primary_10_1016_j_eururo_2013_10_038
crossref_primary_10_1002_1878_0261_12848
crossref_primary_10_3390_cancers12040905
crossref_primary_10_1016_j_ajhg_2012_05_003
crossref_primary_10_1016_j_canlet_2021_12_018
crossref_primary_10_3233_BLC_211609
crossref_primary_10_1016_j_path_2021_05_005
crossref_primary_10_3390_biom12030417
crossref_primary_10_1016_j_cell_2013_03_008
crossref_primary_10_1016_j_phrs_2016_01_026
crossref_primary_10_1016_j_currproblcancer_2016_11_001
crossref_primary_10_1016_j_cell_2013_03_002
crossref_primary_10_1007_s00761_012_2334_7
crossref_primary_10_1016_j_hoc_2014_11_002
crossref_primary_10_1080_15384047_2020_1763148
crossref_primary_10_1016_j_bbrc_2019_06_165
crossref_primary_10_1097_PGP_0b013e31823f8482
crossref_primary_10_4137_BBI_S38427
crossref_primary_10_3389_fonc_2021_670729
crossref_primary_10_1093_gbe_evs083
crossref_primary_10_1016_j_bbagrm_2014_05_014
crossref_primary_10_1158_1078_0432_CCR_17_3646
crossref_primary_10_1016_j_bbcan_2024_189123
crossref_primary_10_1016_j_trsl_2015_08_001
crossref_primary_10_3390_ph5090963
crossref_primary_10_1016_j_pt_2014_05_004
crossref_primary_10_1134_S0006297920070020
crossref_primary_10_1200_JCO_2012_47_8255
crossref_primary_10_4161_epi_24552
crossref_primary_10_1002_humu_21633
crossref_primary_10_1371_journal_pone_0060927
crossref_primary_10_1038_nrurol_2012_142
crossref_primary_10_1186_1471_2407_14_214
crossref_primary_10_1002_cac2_12374
crossref_primary_10_1111_apm_12124
crossref_primary_10_1186_s12885_021_08372_9
crossref_primary_10_1038_aja_2013_29
crossref_primary_10_1210_endocr_bqad071
crossref_primary_10_1007_s11684_012_0182_x
crossref_primary_10_1038_nrurol_2011_220
crossref_primary_10_1016_j_celrep_2021_109943
crossref_primary_10_1038_s41585_024_00857_z
crossref_primary_10_14694_EdBook_AM_2015_35_105
crossref_primary_10_1530_ERC_13_0101
crossref_primary_10_1038_s41388_017_0099_6
crossref_primary_10_1038_s41598_023_42495_2
crossref_primary_10_1007_s00109_016_1395_2
crossref_primary_10_1073_pnas_2310063120
crossref_primary_10_1016_j_bbcan_2024_189253
crossref_primary_10_1097_CM9_0000000000001411
crossref_primary_10_1007_s13721_021_00307_5
crossref_primary_10_1073_pnas_1214168110
crossref_primary_10_1016_j_molcel_2014_02_033
crossref_primary_10_1016_j_ccr_2014_07_018
crossref_primary_10_1038_ng_3076
crossref_primary_10_1210_me_2013_1247
crossref_primary_10_1158_1078_0432_CCR_21_3394
crossref_primary_10_1097_PAP_0000000000000252
crossref_primary_10_1007_s11434_014_0692_9
crossref_primary_10_4103_ijpm_ijpm_95_21
crossref_primary_10_1016_j_envint_2017_10_003
crossref_primary_10_1007_s13277_014_1632_7
crossref_primary_10_1016_j_celrep_2014_04_038
crossref_primary_10_2217_epi_14_31
crossref_primary_10_1016_j_urolonc_2018_02_017
crossref_primary_10_1093_annonc_mdv570
crossref_primary_10_1002_jcla_21981
crossref_primary_10_1007_s00428_017_2119_x
crossref_primary_10_1016_j_cell_2017_09_007
crossref_primary_10_1038_cr_2012_149
crossref_primary_10_1158_1078_0432_CCR_18_3147
crossref_primary_10_1038_nature11606
crossref_primary_10_1007_s13402_016_0276_6
crossref_primary_10_1158_1541_7786_MCR_17_0260
crossref_primary_10_1517_14728222_2014_987662
crossref_primary_10_1194_jlr_R089490
crossref_primary_10_3390_cancers13174414
crossref_primary_10_1186_s13073_015_0144_4
crossref_primary_10_1186_s12894_015_0056_z
crossref_primary_10_1093_annonc_mdu223
crossref_primary_10_1038_modpathol_2012_62
crossref_primary_10_1016_j_ajur_2024_09_006
crossref_primary_10_1038_aps_2017_188
crossref_primary_10_3389_fgene_2020_00377
crossref_primary_10_18632_oncotarget_18668
crossref_primary_10_1371_journal_pone_0090370
crossref_primary_10_1016_j_cll_2023_08_010
crossref_primary_10_1038_cr_2012_136
crossref_primary_10_1158_1078_0432_CCR_13_2499
crossref_primary_10_2217_epi_14_23
crossref_primary_10_2217_epi_2017_0022
crossref_primary_10_1016_j_drup_2012_01_008
crossref_primary_10_1016_j_trecan_2017_04_004
crossref_primary_10_1073_pnas_1313580111
crossref_primary_10_1111_jcmm_16867
crossref_primary_10_1038_s41467_018_05084_w
crossref_primary_10_1007_s10269_015_2512_5
crossref_primary_10_1111_jcmm_70348
crossref_primary_10_1038_sigtrans_2016_45
crossref_primary_10_1002_cam4_70398
crossref_primary_10_1016_j_ajpath_2013_01_007
crossref_primary_10_1186_2047_217X_1_12
crossref_primary_10_3390_ijms232112815
crossref_primary_10_1126_sciadv_aar5598
crossref_primary_10_1002_humu_22520
crossref_primary_10_1038_nrg_2016_13
crossref_primary_10_3390_ijms241512489
crossref_primary_10_1186_s12885_015_1192_2
crossref_primary_10_1371_journal_pgen_1003645
crossref_primary_10_1038_nrd_2016_256
crossref_primary_10_1016_j_semcancer_2019_09_018
crossref_primary_10_1038_ncomms4756
crossref_primary_10_1016_j_semcancer_2015_02_005
crossref_primary_10_1007_s10555_023_10160_9
crossref_primary_10_14694_EdBook_AM_2013_33_195
crossref_primary_10_1038_s10038_020_0736_8
crossref_primary_10_3390_ijms18071449
crossref_primary_10_4143_crt_2021_854
crossref_primary_10_1186_s13073_015_0134_6
crossref_primary_10_1371_journal_pone_0202965
crossref_primary_10_1016_j_semcancer_2012_06_003
crossref_primary_10_1016_j_ebiom_2018_01_044
crossref_primary_10_1007_s00428_016_1977_y
crossref_primary_10_1002_ijc_32116
crossref_primary_10_1016_j_cell_2018_03_017
crossref_primary_10_1038_s41388_020_1218_3
crossref_primary_10_1007_s11912_015_0477_6
crossref_primary_10_1021_acssynbio_9b00349
crossref_primary_10_3390_cancers9010002
crossref_primary_10_1371_journal_pone_0048993
crossref_primary_10_1158_1078_0432_CCR_14_0330
crossref_primary_10_1186_2051_5960_1_19
crossref_primary_10_1101_gr_137596_112
crossref_primary_10_18632_oncotarget_12928
crossref_primary_10_1016_j_ccell_2017_08_005
crossref_primary_10_1016_j_critrevonc_2015_10_021
crossref_primary_10_4161_epi_28298
crossref_primary_10_1038_bjc_2013_126
crossref_primary_10_1093_bfgp_els017
crossref_primary_10_1177_11769351211067692
crossref_primary_10_1186_gb_2013_14_5_r52
crossref_primary_10_1038_nrclinonc_2013_155
crossref_primary_10_1101_cshperspect_a019505
crossref_primary_10_1182_blood_2019001044
crossref_primary_10_1038_nrdp_2017_22
crossref_primary_10_1038_s41375_020_0908_8
crossref_primary_10_1093_hmg_ddt589
crossref_primary_10_1007_s11864_013_0271_3
crossref_primary_10_1016_j_eururo_2013_08_057
crossref_primary_10_1016_j_urolonc_2020_01_019
crossref_primary_10_1172_JCI130445
crossref_primary_10_1155_2016_7593787
crossref_primary_10_1016_j_ccr_2012_06_008
crossref_primary_10_3892_ol_2016_4094
crossref_primary_10_1002_advs_202103999
crossref_primary_10_1002_emmm_201302655
crossref_primary_10_3389_fcell_2023_1181764
crossref_primary_10_2174_1566524023666221221094432
crossref_primary_10_1038_s41598_019_46652_4
crossref_primary_10_1007_s00345_018_2594_y
crossref_primary_10_4161_epi_28078
crossref_primary_10_1158_1078_0432_CCR_14_1768
crossref_primary_10_1101_cshperspect_a026484
crossref_primary_10_1111_febs_13524
crossref_primary_10_1158_2326_6066_CIR_19_0866
crossref_primary_10_1186_gb_2013_14_9_r106
crossref_primary_10_1038_nrc3858
crossref_primary_10_3389_fgene_2021_720421
crossref_primary_10_1002_ijc_27900
crossref_primary_10_1126_scitranslmed_3006200
crossref_primary_10_1186_s13000_020_00976_2
crossref_primary_10_4103_jcrt_JCRT_1090_19
crossref_primary_10_1038_nature12965
crossref_primary_10_1038_nm_3968
crossref_primary_10_1146_annurev_med_060712_200152
crossref_primary_10_3892_ol_2016_4187
crossref_primary_10_14694_EdBook_AM_2014_34_e192
crossref_primary_10_1371_journal_pone_0162515
crossref_primary_10_3390_cancers16111999
crossref_primary_10_1007_s11934_018_0853_5
crossref_primary_10_1038_s41598_017_05004_w
crossref_primary_10_1093_hmg_ddu330
crossref_primary_10_1158_1078_0432_CCR_19_2230
crossref_primary_10_3390_genes6020299
crossref_primary_10_1146_annurev_pathol_012414_040445
crossref_primary_10_1371_journal_pone_0038863
crossref_primary_10_1038_srep14237
crossref_primary_10_1007_s40495_015_0025_y
crossref_primary_10_3109_10408363_2014_906130
crossref_primary_10_1186_s12885_019_5267_3
crossref_primary_10_18632_oncotarget_17279
crossref_primary_10_1038_onc_2014_453
crossref_primary_10_1073_pnas_1210787109
crossref_primary_10_1371_journal_pone_0207776
crossref_primary_10_1126_scitranslmed_aai8312
crossref_primary_10_1007_s00120_014_3756_1
crossref_primary_10_3389_fgene_2022_831146
crossref_primary_10_1038_modpathol_2013_135
crossref_primary_10_1089_scd_2014_0544
crossref_primary_10_1155_2016_3020361
crossref_primary_10_1007_s10555_015_9577_x
crossref_primary_10_1007_s12185_012_1247_y
crossref_primary_10_1016_j_urolonc_2018_10_015
crossref_primary_10_1038_s41598_018_32900_6
crossref_primary_10_1097_PAT_0000000000000110
crossref_primary_10_1158_1078_0432_CCR_14_0257
crossref_primary_10_1016_j_febslet_2012_07_066
crossref_primary_10_2174_0929867325666180706105903
crossref_primary_10_1016_j_pbiomolbio_2022_09_009
crossref_primary_10_3389_fgene_2023_952379
crossref_primary_10_1186_s13046_014_0059_8
crossref_primary_10_2217_epi_15_89
crossref_primary_10_1186_s13000_023_01405_w
crossref_primary_10_1016_j_semcancer_2015_08_006
crossref_primary_10_1016_j_urology_2013_11_027
crossref_primary_10_1038_ng_2493
crossref_primary_10_18632_oncotarget_8404
crossref_primary_10_3233_BLC_200368
crossref_primary_10_1186_s13059_015_0699_9
crossref_primary_10_18632_oncotarget_10539
crossref_primary_10_1186_s12882_016_0390_8
crossref_primary_10_1038_onc_2017_149
crossref_primary_10_1038_s41389_020_00296_6
crossref_primary_10_1016_j_humpath_2014_07_003
crossref_primary_10_1016_j_urolonc_2013_09_019
crossref_primary_10_1016_j_path_2024_09_003
crossref_primary_10_1093_carcin_bgt398
crossref_primary_10_1111_bpa_12030
crossref_primary_10_1016_j_eururo_2013_07_040
crossref_primary_10_1593_neo_121218
crossref_primary_10_1093_jnci_djv080
crossref_primary_10_1002_gcc_22362
crossref_primary_10_1016_j_cancergen_2015_01_005
crossref_primary_10_1093_jrr_rrt227
crossref_primary_10_3389_fgene_2019_00986
crossref_primary_10_1186_gm362
crossref_primary_10_1038_s41416_018_0116_8
crossref_primary_10_1172_JCI67201
crossref_primary_10_1016_j_hoc_2014_10_002
crossref_primary_10_1016_j_ctrv_2017_10_004
crossref_primary_10_1007_s11302_014_9405_8
crossref_primary_10_1111_bpa_12021
crossref_primary_10_1038_nrc3817
crossref_primary_10_5213_inj_1632752_376
crossref_primary_10_1371_journal_pone_0113489
crossref_primary_10_1016_j_cancergen_2014_04_004
crossref_primary_10_1155_2016_1970904
crossref_primary_10_1038_ng_2391
crossref_primary_10_18632_oncotarget_11409
crossref_primary_10_2217_epi_2020_0414
crossref_primary_10_3390_ijms25052750
crossref_primary_10_3892_ol_2021_13106
crossref_primary_10_1038_nrc3929
crossref_primary_10_1093_bfgp_els064
crossref_primary_10_1158_2159_8290_CD_12_0361
crossref_primary_10_1038_nbt_4017
crossref_primary_10_1126_sciadv_aap8747
crossref_primary_10_17650_2618_7019_2024_7_2_25_38
crossref_primary_10_3233_BLC_150024
crossref_primary_10_1038_modpathol_2013_216
crossref_primary_10_1016_j_ygeno_2014_01_003
crossref_primary_10_1684_bdc_2012_1664
crossref_primary_10_1126_science_aad9780
crossref_primary_10_1038_srep40714
crossref_primary_10_1073_pnas_1208807109
crossref_primary_10_1101_cshperspect_a026427
crossref_primary_10_1158_1078_0432_CCR_12_1807
crossref_primary_10_1186_s10020_023_00608_7
crossref_primary_10_1002_bies_201600106
crossref_primary_10_1016_j_eursup_2017_10_003
crossref_primary_10_1007_s11033_014_3359_3
crossref_primary_10_15252_embj_2019103949
crossref_primary_10_1038_s41594_019_0298_7
crossref_primary_10_18632_oncotarget_11207
crossref_primary_10_1111_j_1600_0463_2012_02930_x
crossref_primary_10_4111_icu_2018_59_2_72
crossref_primary_10_1038_ng_2455
crossref_primary_10_1007_s13277_014_2074_y
crossref_primary_10_1016_j_humpath_2013_01_022
crossref_primary_10_1038_ncomms9470
crossref_primary_10_1371_journal_pone_0134346
crossref_primary_10_4161_cbt_28411
crossref_primary_10_1016_j_canlet_2024_217297
crossref_primary_10_1016_j_ydbio_2013_05_018
crossref_primary_10_3389_fimmu_2024_1430792
crossref_primary_10_1038_s41467_020_14595_4
crossref_primary_10_1093_nar_gkaf150
crossref_primary_10_1126_sciadv_1500447
crossref_primary_10_1016_j_eururo_2016_11_003
crossref_primary_10_1182_blood_2014_05_577270
crossref_primary_10_18632_aging_202600
crossref_primary_10_1002_ijc_28705
crossref_primary_10_1016_j_canlet_2015_09_015
crossref_primary_10_1038_s41586_024_07955_3
crossref_primary_10_1016_j_critrevonc_2018_01_009
crossref_primary_10_1016_j_synbio_2016_08_001
crossref_primary_10_1038_s41591_019_0376_8
crossref_primary_10_1177_0960327113499043
crossref_primary_10_1007_s11934_018_0861_5
crossref_primary_10_1016_j_urolonc_2013_06_014
crossref_primary_10_1016_j_eururo_2014_03_028
crossref_primary_10_1007_s11864_014_0319_z
crossref_primary_10_15407_fz66_2_3_083
crossref_primary_10_1038_s41388_018_0192_5
crossref_primary_10_1101_gad_326066_119
crossref_primary_10_1182_blood_2011_12_401471
crossref_primary_10_1073_pnas_1116418109
crossref_primary_10_1126_science_1260200
crossref_primary_10_1002_1878_0261_13360
crossref_primary_10_1007_s00432_018_2625_5
crossref_primary_10_1074_jbc_RA117_001197
crossref_primary_10_1128_JVI_00053_16
crossref_primary_10_1158_0008_5472_CAN_14_1218
crossref_primary_10_1016_j_bulcan_2015_10_004
crossref_primary_10_1111_vco_12740
crossref_primary_10_1002_cncy_21847
crossref_primary_10_1186_s12864_015_1450_3
crossref_primary_10_47248_chp2502010005
crossref_primary_10_7554_eLife_01906
crossref_primary_10_1186_s13046_024_03224_3
crossref_primary_10_1016_j_isci_2020_101201
crossref_primary_10_3390_curroncol29030117
crossref_primary_10_1158_0008_5472_CAN_14_0013
crossref_primary_10_1038_ng_1014
crossref_primary_10_1093_nar_gkac1090
crossref_primary_10_1159_000434683
crossref_primary_10_1038_nrm3327
crossref_primary_10_1111_j_1755_148X_2012_00975_x
crossref_primary_10_1038_nrc3884
crossref_primary_10_1084_jem_20120904
crossref_primary_10_1016_j_humpath_2014_02_013
crossref_primary_10_3390_ijms22020588
crossref_primary_10_1186_s13059_023_03026_4
crossref_primary_10_3390_cancers13236040
crossref_primary_10_18632_oncotarget_355
crossref_primary_10_1038_ng_2894
crossref_primary_10_1186_s13046_022_02321_5
crossref_primary_10_1177_1758835919841235
crossref_primary_10_1016_j_cell_2012_06_013
crossref_primary_10_1038_s41588_018_0114_z
crossref_primary_10_3390_cancers12102792
crossref_primary_10_1136_bmjgast_2014_000010
crossref_primary_10_1371_journal_pone_0161922
crossref_primary_10_3390_jcm9072228
crossref_primary_10_1371_journal_pone_0143042
crossref_primary_10_1002_path_5250
crossref_primary_10_1242_dmm_008888
crossref_primary_10_1038_ng_2643
crossref_primary_10_1002_cam4_4091
crossref_primary_10_3390_ijms140918824
crossref_primary_10_1111_iju_14656
crossref_primary_10_3390_cancers11101480
crossref_primary_10_4161_cbt_28469
crossref_primary_10_1158_1055_9965_EPI_15_0275
crossref_primary_10_1158_0008_5472_CAN_22_1444
crossref_primary_10_1152_ajprenal_00337_2016
crossref_primary_10_1007_s13238_014_0031_6
crossref_primary_10_1016_j_ccr_2014_03_016
crossref_primary_10_1016_j_humpath_2016_04_006
crossref_primary_10_3390_ijms161126000
crossref_primary_10_1371_journal_pone_0062483
crossref_primary_10_1186_s12860_021_00394_2
crossref_primary_10_18632_oncotarget_12473
crossref_primary_10_1038_ng_2799
crossref_primary_10_1038_ng_2798
crossref_primary_10_1016_j_urolonc_2013_07_015
crossref_primary_10_4161_cbt_29687
crossref_primary_10_1038_ncb2916
crossref_primary_10_1016_j_ccell_2021_05_008
crossref_primary_10_1007_s00439_013_1321_4
crossref_primary_10_1182_blood_2012_12_470559
crossref_primary_10_3892_wasj_2020_37
crossref_primary_10_1126_scitranslmed_3006086
crossref_primary_10_1038_onc_2013_227
crossref_primary_10_1126_sciadv_1501354
crossref_primary_10_1007_s11912_014_0404_2
crossref_primary_10_1038_onc_2013_588
crossref_primary_10_1177_0300060519895687
crossref_primary_10_1016_S0140_6736_16_30512_8
crossref_primary_10_1101_sqb_2016_81_031021
crossref_primary_10_1101_cshperspect_a026575
crossref_primary_10_1186_1471_2172_13_9
crossref_primary_10_1101_cshperspect_a026450
Cites_doi 10.1038/sj.onc.1208705
10.1038/12615
10.1101/gr.107524.110
10.1038/nrc1697
10.1016/j.cell.2007.01.029
10.1038/nm1087
10.1126/science.1198056
10.3322/canjclin.55.2.74
10.1038/nature09730
10.1128/MCB.21.18.6091-6101.2001
10.1126/science.1190371
10.1126/science.1133427
10.1038/nature07423
10.1126/science.1138764
10.1056/NEJMoa1008433
10.1101/gr.078212.108
10.1038/nature09639
10.1038/ng.349
10.1093/bioinformatics/btp373
10.1002/ijc.2910560309
10.1016/j.semcancer.2005.01.007
10.1038/cr.2007.10
10.1016/j.febslet.2006.09.049
10.1038/nature09727
10.1038/nature05610
10.1038/nrc2876
10.1093/bioinformatics/btp324
10.1038/nature08672
ContentType Journal Article
Copyright Springer Nature America, Inc. 2011
2015 INIST-CNRS
COPYRIGHT 2011 Nature Publishing Group
Copyright Nature Publishing Group Sep 2011
Copyright_xml – notice: Springer Nature America, Inc. 2011
– notice: 2015 INIST-CNRS
– notice: COPYRIGHT 2011 Nature Publishing Group
– notice: Copyright Nature Publishing Group Sep 2011
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QL
7QP
7QR
7SS
7T7
7TK
7TM
7U9
7X7
7XB
88A
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7N
M7P
MBDVC
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
5PM
DOI 10.1038/ng.907
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Entomology Abstracts (Full archive)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Medical Database
Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Research Library Prep
MEDLINE

MEDLINE - Academic

Genetics Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Agriculture
Biology
EISSN 1546-1718
EndPage 878
ExternalDocumentID PMC5373841
2468662031
A267422214
21822268
24566411
10_1038_ng_907
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States
China
GeographicLocations_xml – name: China
– name: United States
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA075115
– fundername: NIAAA NIH HHS
  grantid: R21 AA022707
GroupedDBID ---
-DZ
-~X
.55
.GJ
0R~
123
29M
2FS
36B
39C
3O-
3V.
4.4
53G
5BI
5M7
5RE
5S5
70F
7X7
85S
88A
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AAEEF
AAHBH
AARCD
AAYOK
AAYZH
AAZLF
ABAWZ
ABCQX
ABDBF
ABDPE
ABEFU
ABJNI
ABLJU
ABOCM
ABTAH
ABUWG
ACBWK
ACGFO
ACGFS
ACIWK
ACMJI
ACNCT
ACPRK
ACUHS
ADBBV
ADFRT
AENEX
AEUYN
AFBBN
AFFNX
AFKRA
AFRAH
AFSHS
AGAYW
AGCDD
AGHTU
AHBCP
AHMBA
AHOSX
AHSBF
AIBTJ
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
ARMCB
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B0M
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CCPQU
CS3
DB5
DU5
DWQXO
EAD
EAP
EBC
EBD
EBS
EE.
EJD
EMB
EMK
EMOBN
EPL
ESX
EXGXG
F5P
FEDTE
FQGFK
FSGXE
FYUFA
GNUQQ
GUQSH
GX1
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IH2
IHR
INH
INR
IOV
ISR
ITC
L7B
LGEZI
LK8
LOTEE
M0L
M1P
M2O
M7P
MVM
N9A
NADUK
NNMJJ
NXXTH
ODYON
P2P
PKN
PQQKQ
PROAC
PSQYO
Q2X
RIG
RNS
RNT
RNTTT
RVV
SHXYY
SIXXV
SJN
SNYQT
SOJ
SV3
TAOOD
TBHMF
TDRGL
TN5
TSG
TUS
UKHRP
VQA
X7M
XJT
XOL
Y6R
YHZ
ZGI
ZXP
ZY4
~8M
~KM
AAYXX
ABFSG
ACMFV
ACSTC
AETEA
AFANA
ALPWD
ATHPR
CITATION
PHGZM
PHGZT
AEZWR
AFHIU
AHWEU
AIXLP
IQODW
NFIDA
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
AEIIB
PMFND
7QL
7QP
7QR
7SS
7T7
7TK
7TM
7U9
7XB
8FD
8FK
C1K
FR3
H94
K9.
M7N
MBDVC
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
RC3
7X8
5PM
ID FETCH-LOGICAL-c688t-609c9b6ff3f796ee4a2bfb8f32669946c72204623572e80d321b3f77196fa07c3
IEDL.DBID 7X7
ISSN 1061-4036
1546-1718
IngestDate Thu Aug 21 13:36:15 EDT 2025
Mon Jul 21 10:44:07 EDT 2025
Fri Jul 11 04:01:57 EDT 2025
Fri Jul 25 09:06:43 EDT 2025
Tue Jun 17 21:48:43 EDT 2025
Tue Jun 10 20:26:08 EDT 2025
Fri Jun 27 03:53:13 EDT 2025
Fri Jun 27 04:17:54 EDT 2025
Thu Apr 03 06:56:03 EDT 2025
Mon Jul 21 09:16:24 EDT 2025
Tue Jul 01 01:50:09 EDT 2025
Thu Apr 24 23:12:37 EDT 2025
Fri Feb 21 02:37:42 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Human
Exon
Urinary system
Nucleotide sequence
Urinary bladder
Malignant tumor
Transitional cell carcinoma
Mutation
Cancer
Chromatin remodeling
Language English
License http://www.springer.com/tdm
CC BY 4.0
Reprints and permissions information is available online at http://www.nature.com/reprints/index.html.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c688t-609c9b6ff3f796ee4a2bfb8f32669946c72204623572e80d321b3f77196fa07c3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
OpenAccessLink http://doi.org/10.1038/ng.907
PMID 21822268
PQID 894124036
PQPubID 33429
PageCount 4
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5373841
proquest_miscellaneous_885907562
proquest_miscellaneous_1034815141
proquest_journals_894124036
gale_infotracmisc_A267422214
gale_infotracacademiconefile_A267422214
gale_incontextgauss_ISR_A267422214
gale_incontextgauss_IOV_A267422214
pubmed_primary_21822268
pascalfrancis_primary_24566411
crossref_primary_10_1038_ng_907
crossref_citationtrail_10_1038_ng_907
springer_journals_10_1038_ng_907
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-09-01
PublicationDateYYYYMMDD 2011-09-01
PublicationDate_xml – month: 09
  year: 2011
  text: 2011-09-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: New York, NY
– name: United States
PublicationTitle Nature genetics
PublicationTitleAbbrev Nat Genet
PublicationTitleAlternate Nat Genet
PublicationYear 2011
Publisher Nature Publishing Group US
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group US
– name: Nature Publishing Group
References Varela (CR15) 2011; 469
Parsons (CR22) 2011; 331
Chi, Allis, Wang (CR16) 2010; 10
Daser, Rabbitts (CR21) 2005; 15
Cairns, Proctor, Knowles (CR7) 1991; 6
Cappellen (CR9) 1999; 23
Sjöblom (CR23) 2006; 314
Getz (CR29) 2007; 317
van Haaften (CR12) 2009; 41
Dalgliesh (CR14) 2010; 463
Pasqualucci (CR19) 2011; 471
Guenther, Barak, Lazar (CR10) 2001; 21
Lutz, Stoger, Nieto (CR11) 2006; 580
Mullighan (CR18) 2011; 471
Koboldt (CR27) 2009; 25
Cordon-Cardo (CR6) 1994; 56
Yi (CR28) 2010; 329
Wu (CR2) 2005; 5
Parkin, Bray, Ferlay, Pisani (CR1) 2005; 55
Greenman (CR5) 2007; 446
Bakkar (CR24) 2003; 63
Wiegand (CR13) 2010; 363
Li, Ruan, Durbin (CR3) 2008; 18
Vogelstein, Kinzler (CR17) 2004; 10
Jones, Baylin (CR25) 2007; 128
Jebar (CR8) 2005; 24
Li, Durbin (CR4) 2009; 25
McKenna (CR26) 2010; 20
Karamouzis, Konstantinopoulos, Papavassiliou (CR20) 2007; 17
Ding (CR30) 2008; 455
PA Jones (BFng907_CR25) 2007; 128
AH Jebar (BFng907_CR8) 2005; 24
GL Dalgliesh (BFng907_CR14) 2010; 463
L Ding (BFng907_CR30) 2008; 455
A Daser (BFng907_CR21) 2005; 15
P Cairns (BFng907_CR7) 1991; 6
H Li (BFng907_CR4) 2009; 25
A McKenna (BFng907_CR26) 2010; 20
G van Haaften (BFng907_CR12) 2009; 41
X Yi (BFng907_CR28) 2010; 329
L Pasqualucci (BFng907_CR19) 2011; 471
XR Wu (BFng907_CR2) 2005; 5
D Cappellen (BFng907_CR9) 1999; 23
C Greenman (BFng907_CR5) 2007; 446
I Varela (BFng907_CR15) 2011; 469
T Sjöblom (BFng907_CR23) 2006; 314
H Li (BFng907_CR3) 2008; 18
T Lutz (BFng907_CR11) 2006; 580
P Chi (BFng907_CR16) 2010; 10
G Getz (BFng907_CR29) 2007; 317
CG Mullighan (BFng907_CR18) 2011; 471
DW Parsons (BFng907_CR22) 2011; 331
MG Guenther (BFng907_CR10) 2001; 21
B Vogelstein (BFng907_CR17) 2004; 10
C Cordon-Cardo (BFng907_CR6) 1994; 56
MV Karamouzis (BFng907_CR20) 2007; 17
AA Bakkar (BFng907_CR24) 2003; 63
DM Parkin (BFng907_CR1) 2005; 55
KC Wiegand (BFng907_CR13) 2010; 363
DC Koboldt (BFng907_CR27) 2009; 25
10471491 - Nat Genet. 1999 Sep;23(1):18-20
19451168 - Bioinformatics. 2009 Jul 15;25(14):1754-60
17027977 - FEBS Lett. 2006 Oct 30;580(25):5851-7
1766677 - Oncogene. 1991 Dec;6(12):2305-9
20644199 - Genome Res. 2010 Sep;20(9):1297-303
14678961 - Cancer Res. 2003 Dec 1;63(23):8108-12
19542151 - Bioinformatics. 2009 Sep 1;25(17):2283-5
20054297 - Nature. 2010 Jan 21;463(7279):360-3
18948947 - Nature. 2008 Oct 23;455(7216):1069-75
17344846 - Nature. 2007 Mar 8;446(7132):153-8
16110317 - Nat Rev Cancer. 2005 Sep;5(9):713-25
15286780 - Nat Med. 2004 Aug;10 (8):789-99
21390126 - Nature. 2011 Mar 10;471(7337):189-95
19330029 - Nat Genet. 2009 May;41(5):521-3
20574448 - Nat Rev Cancer. 2010 Jul;10(7):457-69
15761078 - CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
18714091 - Genome Res. 2008 Nov;18(11):1851-8
17372613 - Cell Res. 2007 Apr;17(4):324-32
20595611 - Science. 2010 Jul 2;329(5987):75-8
21390130 - Nature. 2011 Mar 10;471(7337):235-9
21248752 - Nature. 2011 Jan 27;469(7331):539-42
11509652 - Mol Cell Biol. 2001 Sep;21(18):6091-101
15826832 - Semin Cancer Biol. 2005 Jun;15(3):175-88
16959974 - Science. 2006 Oct 13;314(5797):268-74
21163964 - Science. 2011 Jan 28;331(6016):435-9
20942669 - N Engl J Med. 2010 Oct 14;363(16):1532-43
7906253 - Int J Cancer. 1994 Feb 1;56(3):347-53
15897885 - Oncogene. 2005 Aug 4;24(33):5218-25
17872428 - Science. 2007 Sep 14;317(5844):1500
17320506 - Cell. 2007 Feb 23;128(4):683-92
References_xml – volume: 24
  start-page: 5218
  year: 2005
  end-page: 5225
  ident: CR8
  article-title: and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1208705
– volume: 23
  start-page: 18
  year: 1999
  end-page: 20
  ident: CR9
  article-title: Frequent activating mutations of in human bladder and cervix carcinomas
  publication-title: Nat. Genet.
  doi: 10.1038/12615
– volume: 20
  start-page: 1297
  year: 2010
  end-page: 1303
  ident: CR26
  article-title: The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data
  publication-title: Genome Res.
  doi: 10.1101/gr.107524.110
– volume: 5
  start-page: 713
  year: 2005
  end-page: 725
  ident: CR2
  article-title: Urothelial tumorigenesis: a tale of divergent pathways
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1697
– volume: 128
  start-page: 683
  year: 2007
  end-page: 692
  ident: CR25
  article-title: The epigenomics of cancer
  publication-title: Cell
  doi: 10.1016/j.cell.2007.01.029
– volume: 10
  start-page: 789
  year: 2004
  end-page: 799
  ident: CR17
  article-title: Cancer genes and the pathways they control
  publication-title: Nat. Med.
  doi: 10.1038/nm1087
– volume: 331
  start-page: 435
  year: 2011
  end-page: 439
  ident: CR22
  article-title: The genetic landscape of the childhood cancer medulloblastoma
  publication-title: Science
  doi: 10.1126/science.1198056
– volume: 55
  start-page: 74
  year: 2005
  end-page: 108
  ident: CR1
  article-title: Global cancer statistics, 2002
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/canjclin.55.2.74
– volume: 471
  start-page: 189
  year: 2011
  end-page: 195
  ident: CR19
  article-title: Inactivating mutations of acetyltransferase genes in B-cell lymphoma
  publication-title: Nature
  doi: 10.1038/nature09730
– volume: 21
  start-page: 6091
  year: 2001
  end-page: 6101
  ident: CR10
  article-title: The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.21.18.6091-6101.2001
– volume: 329
  start-page: 75
  year: 2010
  end-page: 78
  ident: CR28
  article-title: Sequencing of 50 human exomes reveals adaptation to high altitude
  publication-title: Science
  doi: 10.1126/science.1190371
– volume: 314
  start-page: 268
  year: 2006
  end-page: 274
  ident: CR23
  article-title: The consensus coding sequences of human breast and colorectal cancers
  publication-title: Science
  doi: 10.1126/science.1133427
– volume: 455
  start-page: 1069
  year: 2008
  end-page: 1075
  ident: CR30
  article-title: Somatic mutations affect key pathways in lung adenocarcinoma
  publication-title: Nature
  doi: 10.1038/nature07423
– volume: 317
  start-page: 1500
  year: 2007
  ident: CR29
  article-title: Comment on “The consensus coding sequences of human breast and colorectal cancers”
  publication-title: Science
  doi: 10.1126/science.1138764
– volume: 363
  start-page: 1532
  year: 2010
  end-page: 1543
  ident: CR13
  article-title: mutations in endometriosis-associated ovarian carcinomas
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1008433
– volume: 18
  start-page: 1851
  year: 2008
  end-page: 1858
  ident: CR3
  article-title: Mapping short DNA sequencing reads and calling variants using mapping quality scores
  publication-title: Genome Res.
  doi: 10.1101/gr.078212.108
– volume: 469
  start-page: 539
  year: 2011
  end-page: 542
  ident: CR15
  article-title: Exome sequencing identifies frequent mutation of the SWI/SNF complex gene in renal carcinoma
  publication-title: Nature
  doi: 10.1038/nature09639
– volume: 41
  start-page: 521
  year: 2009
  end-page: 523
  ident: CR12
  article-title: Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
  publication-title: Nat. Genet.
  doi: 10.1038/ng.349
– volume: 25
  start-page: 2283
  year: 2009
  end-page: 2285
  ident: CR27
  article-title: VarScan: variant detection in massively parallel sequencing of individual and pooled samples
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp373
– volume: 56
  start-page: 347
  year: 1994
  end-page: 353
  ident: CR6
  article-title: p53 mutations in human bladder cancer: genotypic versus phenotypic patterns
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.2910560309
– volume: 6
  start-page: 2305
  year: 1991
  end-page: 2309
  ident: CR7
  article-title: Loss of heterozygosity at the locus is frequent and correlates with muscle invasion in bladder carcinoma
  publication-title: Oncogene
– volume: 15
  start-page: 175
  year: 2005
  end-page: 188
  ident: CR21
  article-title: The versatile mixed lineage leukaemia gene and its many associations in leukaemogenesis
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2005.01.007
– volume: 17
  start-page: 324
  year: 2007
  end-page: 332
  ident: CR20
  article-title: Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis
  publication-title: Cell Res.
  doi: 10.1038/cr.2007.10
– volume: 580
  start-page: 5851
  year: 2006
  end-page: 5857
  ident: CR11
  article-title: CHD6 is a DNA-dependent ATPase and localizes at nuclear sites of mRNA synthesis
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2006.09.049
– volume: 471
  start-page: 235
  year: 2011
  end-page: 239
  ident: CR18
  article-title: mutations in relapsed acute lymphoblastic leukaemia
  publication-title: Nature
  doi: 10.1038/nature09727
– volume: 446
  start-page: 153
  year: 2007
  end-page: 158
  ident: CR5
  article-title: Patterns of somatic mutation in human cancer genomes
  publication-title: Nature
  doi: 10.1038/nature05610
– volume: 10
  start-page: 457
  year: 2010
  end-page: 469
  ident: CR16
  article-title: Covalent histone modifications–miswritten, misinterpreted and mis-erased in human cancers
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2876
– volume: 63
  start-page: 8108
  year: 2003
  end-page: 8112
  ident: CR24
  article-title: and gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder
  publication-title: Cancer Res.
– volume: 25
  start-page: 1754
  year: 2009
  end-page: 1760
  ident: CR4
  article-title: Fast and accurate short read alignment with Burrows-Wheeler transform
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp324
– volume: 463
  start-page: 360
  year: 2010
  end-page: 363
  ident: CR14
  article-title: Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
  publication-title: Nature
  doi: 10.1038/nature08672
– volume: 25
  start-page: 1754
  year: 2009
  ident: BFng907_CR4
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp324
– volume: 21
  start-page: 6091
  year: 2001
  ident: BFng907_CR10
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.21.18.6091-6101.2001
– volume: 331
  start-page: 435
  year: 2011
  ident: BFng907_CR22
  publication-title: Science
  doi: 10.1126/science.1198056
– volume: 317
  start-page: 1500
  year: 2007
  ident: BFng907_CR29
  publication-title: Science
  doi: 10.1126/science.1138764
– volume: 41
  start-page: 521
  year: 2009
  ident: BFng907_CR12
  publication-title: Nat. Genet.
  doi: 10.1038/ng.349
– volume: 20
  start-page: 1297
  year: 2010
  ident: BFng907_CR26
  publication-title: Genome Res.
  doi: 10.1101/gr.107524.110
– volume: 469
  start-page: 539
  year: 2011
  ident: BFng907_CR15
  publication-title: Nature
  doi: 10.1038/nature09639
– volume: 580
  start-page: 5851
  year: 2006
  ident: BFng907_CR11
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2006.09.049
– volume: 23
  start-page: 18
  year: 1999
  ident: BFng907_CR9
  publication-title: Nat. Genet.
  doi: 10.1038/12615
– volume: 10
  start-page: 789
  year: 2004
  ident: BFng907_CR17
  publication-title: Nat. Med.
  doi: 10.1038/nm1087
– volume: 128
  start-page: 683
  year: 2007
  ident: BFng907_CR25
  publication-title: Cell
  doi: 10.1016/j.cell.2007.01.029
– volume: 5
  start-page: 713
  year: 2005
  ident: BFng907_CR2
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1697
– volume: 10
  start-page: 457
  year: 2010
  ident: BFng907_CR16
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2876
– volume: 63
  start-page: 8108
  year: 2003
  ident: BFng907_CR24
  publication-title: Cancer Res.
– volume: 471
  start-page: 235
  year: 2011
  ident: BFng907_CR18
  publication-title: Nature
  doi: 10.1038/nature09727
– volume: 24
  start-page: 5218
  year: 2005
  ident: BFng907_CR8
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1208705
– volume: 463
  start-page: 360
  year: 2010
  ident: BFng907_CR14
  publication-title: Nature
  doi: 10.1038/nature08672
– volume: 6
  start-page: 2305
  year: 1991
  ident: BFng907_CR7
  publication-title: Oncogene
– volume: 455
  start-page: 1069
  year: 2008
  ident: BFng907_CR30
  publication-title: Nature
  doi: 10.1038/nature07423
– volume: 363
  start-page: 1532
  year: 2010
  ident: BFng907_CR13
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1008433
– volume: 471
  start-page: 189
  year: 2011
  ident: BFng907_CR19
  publication-title: Nature
  doi: 10.1038/nature09730
– volume: 17
  start-page: 324
  year: 2007
  ident: BFng907_CR20
  publication-title: Cell Res.
  doi: 10.1038/cr.2007.10
– volume: 314
  start-page: 268
  year: 2006
  ident: BFng907_CR23
  publication-title: Science
  doi: 10.1126/science.1133427
– volume: 446
  start-page: 153
  year: 2007
  ident: BFng907_CR5
  publication-title: Nature
  doi: 10.1038/nature05610
– volume: 25
  start-page: 2283
  year: 2009
  ident: BFng907_CR27
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp373
– volume: 55
  start-page: 74
  year: 2005
  ident: BFng907_CR1
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/canjclin.55.2.74
– volume: 329
  start-page: 75
  year: 2010
  ident: BFng907_CR28
  publication-title: Science
  doi: 10.1126/science.1190371
– volume: 18
  start-page: 1851
  year: 2008
  ident: BFng907_CR3
  publication-title: Genome Res.
  doi: 10.1101/gr.078212.108
– volume: 15
  start-page: 175
  year: 2005
  ident: BFng907_CR21
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2005.01.007
– volume: 56
  start-page: 347
  year: 1994
  ident: BFng907_CR6
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.2910560309
– reference: 1766677 - Oncogene. 1991 Dec;6(12):2305-9
– reference: 17320506 - Cell. 2007 Feb 23;128(4):683-92
– reference: 18948947 - Nature. 2008 Oct 23;455(7216):1069-75
– reference: 15897885 - Oncogene. 2005 Aug 4;24(33):5218-25
– reference: 15761078 - CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
– reference: 10471491 - Nat Genet. 1999 Sep;23(1):18-20
– reference: 20574448 - Nat Rev Cancer. 2010 Jul;10(7):457-69
– reference: 11509652 - Mol Cell Biol. 2001 Sep;21(18):6091-101
– reference: 18714091 - Genome Res. 2008 Nov;18(11):1851-8
– reference: 20644199 - Genome Res. 2010 Sep;20(9):1297-303
– reference: 21248752 - Nature. 2011 Jan 27;469(7331):539-42
– reference: 21390126 - Nature. 2011 Mar 10;471(7337):189-95
– reference: 17344846 - Nature. 2007 Mar 8;446(7132):153-8
– reference: 7906253 - Int J Cancer. 1994 Feb 1;56(3):347-53
– reference: 16959974 - Science. 2006 Oct 13;314(5797):268-74
– reference: 15826832 - Semin Cancer Biol. 2005 Jun;15(3):175-88
– reference: 14678961 - Cancer Res. 2003 Dec 1;63(23):8108-12
– reference: 20595611 - Science. 2010 Jul 2;329(5987):75-8
– reference: 21163964 - Science. 2011 Jan 28;331(6016):435-9
– reference: 19542151 - Bioinformatics. 2009 Sep 1;25(17):2283-5
– reference: 17372613 - Cell Res. 2007 Apr;17(4):324-32
– reference: 20942669 - N Engl J Med. 2010 Oct 14;363(16):1532-43
– reference: 21390130 - Nature. 2011 Mar 10;471(7337):235-9
– reference: 19330029 - Nat Genet. 2009 May;41(5):521-3
– reference: 15286780 - Nat Med. 2004 Aug;10 (8):789-99
– reference: 20054297 - Nature. 2010 Jan 21;463(7279):360-3
– reference: 19451168 - Bioinformatics. 2009 Jul 15;25(14):1754-60
– reference: 17872428 - Science. 2007 Sep 14;317(5844):1500
– reference: 17027977 - FEBS Lett. 2006 Oct 30;580(25):5851-7
– reference: 16110317 - Nat Rev Cancer. 2005 Sep;5(9):713-25
SSID ssj0014408
Score 2.5688918
Snippet Zhiming Cai and colleagues report the exome sequencing of tumor and matched normal tissue from nine transitional cell carcinomas (TCCs) of the bladder, with...
Transitional cell carcinoma (TCC) is the most common type of bladder cancer. Here we sequenced the exomes of nine individuals with TCC and screened all the...
SourceID pubmedcentral
proquest
gale
pubmed
pascalfrancis
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 875
SubjectTerms 631/208/2489/144/68
631/337/100/102
692/699/67/589/1336
Adenocarcinoma
Agriculture
Animal Genetics and Genomics
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Cancer
Cancer Research
Carcinoma, Transitional Cell - genetics
Chromatin Assembly and Disassembly - genetics
Chromosome Aberrations
Classical genetics, quantitative genetics, hybrids
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation, Neoplastic
Gene Function
Gene mutations
Genes
Genetic aspects
Genetics
Genetics of eukaryotes. Biological and molecular evolution
Human
Human Genetics
Humans
letter
Mutation
Polymerase chain reaction
Urinary Bladder Neoplasms - genetics
Title Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
URI https://link.springer.com/article/10.1038/ng.907
https://www.ncbi.nlm.nih.gov/pubmed/21822268
https://www.proquest.com/docview/894124036
https://www.proquest.com/docview/1034815141
https://www.proquest.com/docview/885907562
https://pubmed.ncbi.nlm.nih.gov/PMC5373841
Volume 43
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagFRISQrwJLYtBIE6hm8Rx7BMqVVcFiYIKRXsishN7W6l1tkn2wL9nJs6mhFIuOcQTx4_xeDwzno-Q17E2sRIg_Swr4YCSljrUkVahlNZoDYtLdRn4Ph_yg2P2aZ7O-9icpg-rXMvETlCXVYE28h0hEScZ5O375UWIoFHoXO0RNG6STcxchkydzYfzFrot_U04jsck9FJ6aKFE7LjFO4kIsn_sRb1EvrNUDYyO9bAW_9I7r4ZP_uVD7bam2T1yt9cp6a5ngvvkhnEPyC2PMvnrIfk5q7t46Zaer7zjvaGVpcVJXaG66mhtOjwcqJsuUPRReNfiHnbqDYUUrfu0QNQhB5_gx6A2Un2GUqt-RI5n-9_3DsIeViEsuBBtyKeykJpbm9hMcmOYirXVwoIix6VkvMjiGK-sJmkWGzEtkzjSQJrBWrVqmhXJY7LhKmeeEipUxpi2qIVIZiycpm2qoT4lyjQC3gjIm_UA50WfcxyhL87yzvediNwtcpiIgLwY6JY-y8YVilc4PzmmrHAYE7NQq6bJP375ke_GPENDVsSuI_p2NCJ62xPZCtpSqP4eAvQIU2GNKLdHlLDwilHxZMQrQ8vRl8xZFAVka808eS8Zmnzg44C8HEqxZgx2c6ZaNdhtTKETMaiBXkMjRAqjAsprQJ54brz8fYRKHxcByUZ8OhBgRvFxiTs96TKLp5jnqvvtmqMvGz6ej2f_7dsWue1t7xiLt0022nplnoPy1upJt0ThKfaiCdn8sH_49eg3-uVHRg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgQSQrwJLa1BVJxCN4njOAeEqsJqlz6QoEU9EeLE3lYqybLZFeqP4j8yEycpoZRbr_HY8WM8HnseH8BLX2k_lSj9DM_xghLmylWeSt04Nlop3FxpnYFvb1-MDvmHo_BoCX61sTDkVtnKxFpQ52VGb-SbMiacZJS3b6c_XAKNIuNqi6BhuWJHn_3EG1v1ZvwOl3fD94fvD7ZHbgMq4GZCyrkrBnEWK2FMYKJYaM1TXxklDaoxIo65yCLfp4DNIIx8LQd54HsKSSPkVJMOoizAdq_BdR7gzqTA9O3Oo4TMpDbyTtC1jKyiFsookJvF5HVMiLV_nH3NCXB7mla4GsbCaPxLz73orvmXzbY-Cod34U6jw7Ity3T3YEkX9-GGRbU8ewBfh7PaP3vOvi-sob9ipWHZ8awk9bhgM13j72DbbEKiluG3OZ2ZJ_ZhkpE1gWWEclRgFaqMaipTpyQlZw_h8Epm_BEsF2WhnwCTacS5MqT1xFwbvL2bUGF7qcxDD3nRgY12gpOsyXFOUBunSW1rD2RSTBJcCAfWO7qpzepxgeIFrU9CKTIK8sGZpIuqSsYfvyRbvojo4czjlxF9_tQjetUQmRL7kqVN3AOOiFJv9ShXe5S40bNe8VqPV7qek-1acM9zYKVlnqSRRFXS7RsHnnel1DI51xW6XFQ0bErZ43FsgV1CI2WIs4LKsgOPLTee_94jJVNIB6Ien3YElMG8X1KcHNeZzEPKq1X_tuXo84731-Ppf8e2DjdHB3u7ye54f2cFbtl3f_IDXIXl-Wyhn6HiOFdr9XZl8O2q5cNv9i6AHA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9QwDLfGEAgJIb4pG1tATDyVu36l6QNC08Zpx2AgYNOeKE2b3CaN9mh7QvvT-O-wm7ajjPG218ZJk9hxnNjxD-C5K5WbCNR-2s_wgBJk0paOTOwo0kpKXFxJk4Hv_R7f2fffHgaHS_CrewtDYZWdTmwUdVakdEc-EhHhJKO-Hek2KuLj9uT1_IdNAFLkaO3QNIyE7KrTn3h6q15Nt5HVG647efNla8duAQbslAtR23wcpZHkWns6jLhSfuJKLYVGk4ZHkc_T0HXp8aYXhK4S48xzHYmkIUqtTsZh6mG7V-Bq6IWClpjY6qNLyGVqXuFxOqKRh9TAGnlilM9eRoRe-8c-2O4GN-dJhZzRBlLjXzbv-dDNv_y3zbY4uQ23WnuWbRoBvANLKr8L1wzC5ek9-Dopm1jtmn1fGKd_xQrN0qOyIFM5Z6VqsHiwbTYjtcvwW03757G5pGTkWWApIR7lWIUqo8nK5AlpzPI-7F_KjD-A5bzI1SNgIgl9X2qygCJfaTzJ60Bie4nIAgfl0oKNboLjtM13TrAbJ3Hjd_dEnM9iZIQF6z3d3GT4OEfxjPgTU7qMnCRvliyqKp5-OIg3XR7SJZrjX0T0-dOA6EVLpAvsS5q0byBwRJSGa0C5OqDERZ8OitcGstL3nPzY3HccC1Y64YlbrVTF_Rqy4GlfSi1ToF2uikVFw6b0PY6PLbALaIQIcFbQcLbgoZHGs987ZHByYUE4kNOegLKZD0vy46Mmq3lAObaa33YSfdbxIT8e_3ds63AdNUP8brq3uwI3jAuAQgJXYbkuF-oJ2pC1XGtWK4Nvl60efgMCbYRS
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Frequent+mutations+of+chromatin+remodeling+genes+in+transitional+cell+carcinoma+of+the+bladder&rft.jtitle=Nature+genetics&rft.au=Gui%2C+Yaoting&rft.au=Guo%2C+Guangwu&rft.au=Huang%2C+Yi&rft.au=Hu%2C+Xueda&rft.date=2011-09-01&rft.pub=Nature+Publishing+Group+US&rft.issn=1061-4036&rft.eissn=1546-1718&rft.volume=43&rft.issue=9&rft.spage=875&rft.epage=878&rft_id=info:doi/10.1038%2Fng.907&rft.externalDocID=10_1038_ng_907
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1061-4036&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1061-4036&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1061-4036&client=summon